Cash Equivalents - HK Inno.N Corp (KOSDAQ:195940) - Alpha Spread
H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 50 400 KRW -0.2% Market Closed
Market Cap: 1.4T KRW
Have any thoughts about
HK Inno.N Corp?
Write Note

HK Inno.N Corp
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

HK Inno.N Corp
Cash Equivalents Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
H
HK Inno.N Corp
KOSDAQ:195940
Cash Equivalents
â‚©107.7B
CAGR 3-Years
28%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Cash Equivalents
â‚©279B
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
6%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash Equivalents
â‚©239.7B
CAGR 3-Years
59%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash Equivalents
â‚©47.9B
CAGR 3-Years
-35%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash Equivalents
â‚©4.6B
CAGR 3-Years
-61%
CAGR 5-Years
-37%
CAGR 10-Years
-18%
C
Celltrion Pharm Inc
KOSDAQ:068760
Cash Equivalents
â‚©12.2B
CAGR 3-Years
-33%
CAGR 5-Years
5%
CAGR 10-Years
5%

See Also

What is HK Inno.N Corp's Cash Equivalents?
Cash Equivalents
107.7B KRW

Based on the financial report for Dec 31, 2023, HK Inno.N Corp's Cash Equivalents amounts to 107.7B KRW.

What is HK Inno.N Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
15%

Over the last year, the Cash Equivalents growth was -3%. The average annual Cash Equivalents growth rates for HK Inno.N Corp have been 28% over the past three years , 15% over the past five years .

Back to Top